These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 31700973)
41. Skin and metabolic syndrome: A review of the possible associations. Adibi N; Robati RM J Res Med Sci; 2021; 26():16. PubMed ID: 34084195 [TBL] [Abstract][Full Text] [Related]
42. Testosterone and metabolic syndrome. Cunningham GR Asian J Androl; 2015; 17(2):192-6. PubMed ID: 25652634 [TBL] [Abstract][Full Text] [Related]
43. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Engmann L; Jin S; Sun F; Legro RS; Polotsky AJ; Hansen KR; Coutifaris C; Diamond MP; Eisenberg E; Zhang H; Santoro N; Am J Obstet Gynecol; 2017 May; 216(5):493.e1-493.e13. PubMed ID: 28104402 [TBL] [Abstract][Full Text] [Related]
45. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset. Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027 [TBL] [Abstract][Full Text] [Related]
46. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected? Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949 [TBL] [Abstract][Full Text] [Related]
48. Acne as a chronic systemic disease. Zouboulis CC Clin Dermatol; 2014; 32(3):389-96. PubMed ID: 24767186 [TBL] [Abstract][Full Text] [Related]
49. Effects of sex steroids on women's health: implications for practitioners. Derman RJ Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634 [TBL] [Abstract][Full Text] [Related]
51. Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study. Moon H; Choi I; Kim S; Ko H; Shin J; Lee K; Sung J; Song YM Clin Endocrinol (Oxf); 2017 Nov; 87(5):523-531. PubMed ID: 28581026 [TBL] [Abstract][Full Text] [Related]
52. Association of insulin resistance with hyperandrogenia in women. Pugeat M; Ducluzeau PH; Mallion-Donadieu M Horm Res; 2000; 54(5-6):322-6. PubMed ID: 11595827 [TBL] [Abstract][Full Text] [Related]
53. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women. Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977 [TBL] [Abstract][Full Text] [Related]
54. Association of Perforin and Granzyme-B Levels with Hyperandrogenism in Polycystic Ovary Syndrome: A Case-Control Study. Zarei E; Mohajery H; Aliakbari F; Zadeh FM; Veghari G; Mansourian A Pak J Biol Sci; 2019 Jan; 22(8):393-399. PubMed ID: 31930827 [TBL] [Abstract][Full Text] [Related]
55. Correlation of Skin Changes with Hormonal Changes in Polycystic Ovarian Syndrome: A Cross-sectional Study Clinical Study. Gowri BV; Chandravathi PL; Sindhu PS; Naidu KS Indian J Dermatol; 2015; 60(4):419. PubMed ID: 26288423 [TBL] [Abstract][Full Text] [Related]
56. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features. Taketani Y; Mizuno M Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357 [TBL] [Abstract][Full Text] [Related]
57. [Woman 19-old with hirsutism, obesity and acanthosis nigricans]. Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516 [TBL] [Abstract][Full Text] [Related]